PHC Holdings Corporation
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Analyst Recommendations 7 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/13 | ¥15.83 | ¥-1.60 | -110.1% |
| 2026/02/12 | ¥13.50 | ¥9.92 | -26.5% |
| 2025/11/11 | ¥45.88 | ¥14.13 | -69.2% |
| 2025/08/06 | ¥3.95 | ¥-18.55 | -569.6% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
406.3K | 0.00% | |
|
WisdomTree Trust-WisdomTree Japan Hedged Equity Fund
|
350.4K | +6.57% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
260.2K | +11.15% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
149.5K | +32.53% | |
|
Dimensional ETF Trust-Dimensional International Small Cap Value ETF
|
149.9K | +16.11% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
131.7K | 0.00% |
Dividend History
Updated 2026/08/23| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥21 | -50.0% |
| 2025 | ¥42 | +7.7% |
| 2024 | ¥39 | -45.8% |
| 2023 | ¥72 | -2.7% |
| 2022 | ¥74 | - |
Financial Performance
2026/08/23 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥340,452M | ¥356,434M | ¥353,900M | ¥361,593M |
| Gross Profit | ¥165,237M | ¥169,132M | ¥157,975M | ¥166,224M |
| Operating Income | ¥8,529M | ¥20,515M | ¥1,738M | ¥22,952M |
| Pretax Income | ¥10,522M | ¥20,410M | ¥2,215M | ¥24,085M |
| Net Income | -¥8,460M | -¥3,221M | -¥12,892M | ¥10,484M |
| EPS | -¥70.78 | -¥25.84 | -¥102.48 | ¥82.58 |
| Operating Margin | 2.51% | 5.76% | 0.49% | 6.35% |
| Balance Sheet | ||||
| Total Assets | ¥591,320M | ¥561,567M | ¥564,327M | ¥532,482M |
| Total Equity | ¥135,374M | ¥138,008M | ¥139,515M | ¥141,639M |
| Total Liabilities | ¥455,946M | ¥423,559M | ¥424,812M | ¥390,843M |
| Cash | ¥95,232M | ¥60,933M | ¥47,044M | ¥39,592M |
| Interest-bearing Debt | ¥307,936M | ¥292,615M | ¥285,045M | ¥255,260M |
| Equity Ratio | 22.89% | 24.58% | 24.72% | 26.60% |
| D/E Ratio | 2.27 | 2.12 | 2.04 | 1.80 |
| Cash Flow | ||||
| Operating CF | ¥51,053M | ¥21,376M | ¥41,304M | ¥41,941M |
| Investing CF | -¥12,521M | -¥17,520M | -¥21,072M | -¥8,473M |
| Financing CF | -¥7,015M | -¥40,832M | -¥39,139M | -¥39,068M |
| Free CF | ¥39,317M | ¥9,860M | ¥26,674M | ¥30,331M |
| Efficiency | ||||
| ROE | -6.25% | -2.33% | -9.24% | 7.40% |
| ROA | -1.43% | -0.57% | -2.28% | 1.97% |
Latest IR Information
-
PHC Holdings Corporation First Quarter IFRS Consolidated Financial Results Report (IFRS)
For the first quarter of the fiscal year ending March 2027, consolidated net sales were 90,672 million yen (YoY +8.1%), operating income was 10,413 million yen (+171.0% YoY), and net income for the period was 6,293 million yen, indicating solid...
Read more -
【PHC Holdings】Notice Regarding Controlling Shareholder｜June 2026
PHC Holdings Corporation owns 37.96% of voting rights from KKR PHC Investment L.P. as of the end of March 2026, maintaining its relationship within the group. There are no significant transactions, and it discloses information regarding the controlling shareholder.
Read more -
Regarding the Conclusion of a Loan Agreement with Financial Covenants
PHC Holdings Corporation concluded a syndicated loan agreement totaling approximately 174.4 billion yen on March 19, 2026, to secure working capital and refinance existing borrowings.
Read more -
Notice Regarding the Business Transfer of a Consolidated Subsidiary
PHC Holdings has resolved to transfer the Continuous Glucose Monitoring (CGM) system Eversense sales business of its consolidated subsidiary Ascensia Diabetes Care Holdings AG to Senseonics Holdings, Inc. for 1.1 million USD plus the net amount of transferred assets and...
Read more
Latest News (5 items)
-
Average Analyst Rating: hold
Average Target Price: ¥1,293
Rating Score: 2.71 (Based on 7 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management, Healthcare Solutions, and Diagnostics & Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and cell expansion bioreactor system; and diagnostic testing comprising clinical testing, diagnostic reagents, and digital diabetes management solutions. The company also provides patient record and billing solutions, which include electronic medical record systems and receipt systems, systems for pharmacies, and wellness and prevention; diabetes management technology, such as blood and continuous glucose monitoring systems; and medical device and drug delivery comprising contract development and manufacturing services, drug delivery systems, and digital health. It serves patients, healthcare professionals, and researchers. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. PHC Holdings Corporation was founded in 1948 and is headquartered in Chiyoda, Japan.
